Keith William Pratz

机构：Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Abramson Cancer Center, University of Pennsylvania · ORCID：0000-0002-1284-8266

发表论文 307 篇 · 总被引 15643 次 · h-index 49

代表论文

• Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults (2024 · New England Journal of Medicine · 被引 272)
• Long‐term follow‐up of VIALE‐A : Venetoclax and azacitidine in chemotherapy‐ineligible untreated acute myeloid leukemia (2024 · American Journal of Hematology · 被引 226)
• Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine (2024 · Blood · 被引 150)
• Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology (2024 · Journal of the National Comprehensive Cancer Network · 被引 139)
• Ziftomenib Combined with Venetoclax/Azacitidine in Relapsed/Refractory NPM1 -m or KMT2A -r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007 (2024 · Blood · 被引 27)
• The impact of post‐remission granulocyte colony‐stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia (2024 · American Journal of Hematology · 被引 18)